compare glp 1 providers GLP-1 Options | Ozempic v Mounjaro | WeightWatchers Best GLP1 Providers in the
Description
Endocrine 66 (2), 157165 (2019)
The median duration of GLP-1 receptor agonists therapy was 1.4 years, and 31% of the patients discontinued the drug, 7% due to nausea and 5% due to vomiting
In the UK, clearer guidance carries more weight, reflecting the influence of centralized decision-making and prescribing frameworks
Sci Transl Med, 10(467):eaar7047
doi: 10.3389/fendo.2019.00155
6e and Supplementary Fig
